Concepedia

Publication | Open Access

Safety and Efficacy of Durvalumab With or Without Tremelimumab in Patients With PD-L1–Low/Negative Recurrent or Metastatic HNSCC

DOIFull Paper Access

306

Citations

25

References

2018

Year

Lillian L. Siu, Caroline Even, Éva Remenár, Amaury Daste, Jean‐Pierre Delord, Nabil F. Saba, Lisle M. Nabell, Neal Ready, Irene Braña, Nuria Kotecki,
JAMA Oncology

Abstract

clinicaltrials.gov Identifier: NCT02319044.

References

YearCitations

Page 1